X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 53 filers reported holding X4 PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,775,531 | -43.8% | 7,133,515 | 0.0% | 0.16% | -34.3% |
Q2 2023 | $13,839,019 | +173.4% | 7,133,515 | +22.6% | 0.25% | +153.5% |
Q1 2023 | $5,061,422 | -12.4% | 5,817,726 | 0.0% | 0.10% | -10.8% |
Q4 2022 | $5,777,002 | -32.8% | 5,817,726 | +15.7% | 0.11% | -30.6% |
Q3 2022 | $8,596,000 | +548.3% | 5,026,817 | +265.9% | 0.16% | +566.7% |
Q2 2022 | $1,326,000 | -44.8% | 1,373,849 | 0.0% | 0.02% | -38.5% |
Q1 2022 | $2,404,000 | -23.6% | 1,373,849 | 0.0% | 0.04% | -2.5% |
Q4 2021 | $3,146,000 | -56.7% | 1,373,849 | 0.0% | 0.04% | -50.0% |
Q3 2021 | $7,268,000 | -18.6% | 1,373,849 | 0.0% | 0.08% | -11.1% |
Q2 2021 | $8,930,000 | -24.5% | 1,373,849 | 0.0% | 0.09% | -18.9% |
Q1 2021 | $11,829,000 | +69.3% | 1,373,849 | +26.4% | 0.11% | +82.0% |
Q4 2020 | $6,986,000 | -5.0% | 1,086,493 | 0.0% | 0.06% | -33.7% |
Q3 2020 | $7,356,000 | -27.4% | 1,086,493 | 0.0% | 0.09% | -35.7% |
Q2 2020 | $10,126,000 | -6.8% | 1,086,493 | 0.0% | 0.14% | -21.9% |
Q1 2020 | $10,865,000 | -6.5% | 1,086,493 | 0.0% | 0.18% | +10.2% |
Q4 2019 | $11,625,000 | -2.3% | 1,086,493 | +16.0% | 0.17% | -26.5% |
Q3 2019 | $11,903,000 | -15.3% | 936,493 | 0.0% | 0.23% | +3.7% |
Q2 2019 | $14,047,000 | +159.0% | 936,493 | +200.6% | 0.22% | +159.5% |
Q1 2019 | $5,423,000 | – | 311,493 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10,616 | 1.33% |
Tri Locum Partners LP | 3,878,484 | $3,374,281 | 1.03% |
Lynwood Capital Management Inc. | 900,000 | $783,000 | 0.71% |
NEA Management Company, LLC | 11,736,793 | $10,211,010 | 0.71% |
Parkman Healthcare Partners LLC | 2,797,147 | $2,433,518 | 0.53% |
SCOGGIN MANAGEMENT LP | 484,796 | $567,025 | 0.33% |
New Leaf Venture Partners, L.L.C. | 335,000 | $291,450 | 0.24% |
Ghost Tree Capital, LLC | 850,000 | $740,000 | 0.22% |
Perceptive Advisors | 4,545,454 | $3,954,545 | 0.12% |
Orbimed Advisors | 5,817,726 | $5,061,422 | 0.10% |